MEDOF logo

MEDOF Medios AG

Other OTC · Medical - Distribution · Healthcare

$50.00
+0.00 (+0.00%)

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and pa…

Market Cap: $1.28Bmedios.group

Price

No data yet.

Signal Score (90d)

100
100
Aug 17Aug 17

Revenue

$527.62M+65.39%
$319.02M$395.56M$472.11M$548.65M
Jun 2021Mar 2026

Quote

Day Range
$13.64 – $50.00
52-Week Range
$13.64 – $50.00
Volume
$2.0K
Market Cap
$1.28B
50-Day Avg
$50.00
200-Day Avg
$50.00
Prev Close
$50.00
Open
$13.64

Valuation & Ratios

P/E Ratio
69.76
EPS
$0.61
P/B Ratio
2.07
P/S Ratio
0.51
Debt/Equity
0.37
Current Ratio
1.90
Dividend Yield
+0.0%
Gross Margin
+9.6%

Returns & Efficiency

Return on Equity
+3.0%
Return on Assets
+1.7%
FCF Yield
+4.1%
EV/EBITDA
13.82

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$2.08B$15.37M$0.61
2024$1.88B$12.55M$0.51
2023$1.78B$18.81M$0.79
2022$1.61B$18.33M$0.77
2021$1.36B$7.40M$0.37

Social Signal Score

50
5d
51
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Tue, Nov 10(in 3 months)

3of 4 quarters beat consensus

Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Nov 11$0.34 vs $0.34beat
  • Wed, Aug 13$0.35 vs $0.29beat
  • Tue, May 13$0.26 vs $0.26beat
  • Tue, Mar 4$0.09 vs $0.26miss

Estimates and results for MEDOF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from MEDOF's reported EPS growth of 13.3% a year over 4 years.

EPS in 5 years
$1.15
Implied price
$20.62
Return from $50.00
-16.2% a year

To earn 15.0% a year on these assumptions you'd need to buy at $10.25 -79.5% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E1215182124
3.3%-29.6%-26.4%-23.6%-21.2%-19.1%
8.3%-26.2%-22.8%-19.9%-17.4%-15.2%
13.3%-22.8%-19.2%-16.2%-13.6%-11.3%
18.3%-19.4%-15.7%-12.5%-9.8%-7.4%
23.3%-15.9%-12.1%-8.8%-6.0%-3.4%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsseekingalpha.com·5h ago·Neutral

    Medios AG (MEDOF) Q2 2026 Earnings Call Prepared Remarks Transcript Medios AG (MEDOF) Q2 2026 Earnings Call Prepared Remarks Transcript

    View source ↗